Assess the Safety & Reactogenicity of GSK Biologicals Hib Vaccine co-Administered With Chinese Local DTPw Vaccine When Compared to Chinese Local DTPw Vaccine Administered Alone, in Healthy Infants at 3,4 & 5 Mths of Age

Trial Profile

Assess the Safety & Reactogenicity of GSK Biologicals Hib Vaccine co-Administered With Chinese Local DTPw Vaccine When Compared to Chinese Local DTPw Vaccine Administered Alone, in Healthy Infants at 3,4 & 5 Mths of Age

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Hib vaccine conjugate (Primary) ; Diphtheria tetanus and pertussis vaccine
  • Indications Diphtheria; Haemophilus infections; Pertussis; Tetanus
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Oct 2006 Status change
    • 11 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top